A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

Ann Rheum Dis. 2002 Oct;61(10):941-2. doi: 10.1136/ard.61.10.941.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Juvenile / drug therapy*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Prospective Studies
  • Spondylitis, Ankylosing / drug therapy*
  • Sulfasalazine / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Sulfasalazine